S
The startup develops regenerative healing technology that preserves the complete structure of human placental membranes, including the epithelial layer and Wharton's jelly, in a shelf-stable format. This technology provides the healthcare sector with a reliable allograft solution for enhancing regenerative medicine applications.
Updated 3 months ago
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops regenerative healing technology that preserves the complete structure of human placental membranes, including the epithelial layer and Wharton's jelly, in a shelf-stable format. This technology provides the healthcare sector with a reliable allograft solution for enhancing regenerative medicine applications.